Getting to the heart of the matter...
Welcome to CorDynamics, a contract laboratory and consulting group focused on examining the cardiac effects of emerging drug candidates.
Are you looking for a way to define the cardiovascular profile of your lead compounds— accurately, quickly and affordably— with customized approaches? CorDynamics is an international industry leader in cardiac safety, providing proven, specialized techniques to help our clients get their products to market— from drug discovery assessments and lead optimization with drug screening to regulatory compliant studies and consulting expertise. By focusing on these critical and dynamic phases of drug development, our goal is to improve the attrition rate of compounds selected for further testing, thereby reducing your overall costs and timelines.

Webinars
CEO Dr. Michael Gralinski gives an in-depth look at the services CorDynamics provides, complete with illustrations of models and data in perspective.
The CorDynamics telemetry team marked its one-year anniversary. This dedicated group has successfully provided telemetry studies for clients looking at cardiovascular effects of new molecular entities in a variety of drug development phases.